510(k) K161100
K161100 is an FDA 510(k) premarket notification submitted by Contamac, Ltd. for the device "Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact Lenses". The FDA issued a decision of Substantially Equivalent on Aug 10, 2016. The device falls under product code HQD (Lens, Contact (Other Material) - Daily), a Class II device regulated under 21 CFR 886.5916. Contamac, Ltd. has 17 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 10, 2016
- Date Received
- Apr 19, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Lens, Contact (Other Material) - Daily
- Device Class
- Class II
- Regulation Number
- 886.5916
- Review Panel
- OP
- Submission Type
- 510(k)